blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3267808

EP3267808 - WATER DISPERSIBLE STEROL/STANOL ENRICHED POLYPHENOL RICH HERBAL TEAS IN AQUEOUS OR POWDERED FORMS TO REDUCE TOTAL AND LDL CHOLESTEROL LEVELS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.02.2020
Database last updated on 03.06.2024
FormerThe patent has been granted
Status updated on  22.03.2019
FormerGrant of patent is intended
Status updated on  30.10.2018
FormerRequest for examination was made
Status updated on  15.12.2017
FormerThe international publication has been made
Status updated on  07.02.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Tubitak
Ataturk Bulvari, No 221
Kavaklidere / Cankaya
06100 Ankara / TR
[2018/03]
Inventor(s)01 / ALASALVAR, Cesarettin
Tübitak
Marmara Arastirma Merkezi
Gida Enstitüsü PK21
41470 Kocaeli / TR
02 / KARADAG, Ayse
Yildiz Teknik Üniversitesi
Gida Mühendisligi
Bölümü
34210 Esenler Istanbul / TR
03 / PELVAN, Ebru
Tübitak
Marmara Arastirma Merkezi
Gida Enstitüsü PK21
41470 Kocaeli / TR
 [2019/15]
Former [2018/03]01 / ALASALVAR, Cesarettin
Tübitak
Marmara Arastirma Merkezi
G da Enstitüsü PK21
41470 Kocaeli / TR
02 / KARADAG, Ayse
Tübitak
Marmara Arastirma Merkezi
G da Enstitüsü PK21
41470 Kocaeli / TR
03 / PELVAN, Ebru
Tübitak
Marmara Arastirma Merkezi
G da Enstitüsü PK21
41470 Kocaeli / TR
Application number, filing date15714942.811.03.2015
[2018/03]
WO2015IB51765
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016142745
Date:15.09.2016
Language:EN
[2016/37]
Type: A1 Application with search report 
No.:EP3267808
Date:17.01.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 15.09.2016 takes the place of the publication of the European patent application.
[2018/03]
Type: B1 Patent specification 
No.:EP3267808
Date:24.04.2019
Language:EN
[2019/17]
Search report(s)International search report - published on:EP15.09.2016
ClassificationIPC:A23L33/10, A23L2/52, A23F3/16, A23L11/00, A23L29/10
[2018/03]
CPC:
A23F3/16 (EP); A23F3/30 (EP,KR); A23F3/163 (EP,KR);
A23F3/34 (EP,KR); A23L2/52 (EP,KR); A23L33/105 (EP,KR);
A23L33/11 (EP,KR); A61K31/05 (EP); A61K31/575 (EP);
A61K36/82 (KR); A61P3/06 (EP); A61P9/06 (EP);
A61P9/10 (EP); A23V2002/00 (KR); A23V2250/214 (KR);
A61K36/00 (EP) (-)
C-Set:
A61K31/05, A61K2300/00 (EP);
A61K31/575, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/03]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:WASSERDISPERGIERBARE, MIT STEROL/STANOL ANGEREICHERTE KRÄUTERTEES MIT HOHEM POLYPHENOLGEHALT IN WÄSSRIGER FORM ODER PULVERFORM ZUR REDUZIERUNG DES GESAMT- UND DES LDL-CHOLESTERINSPIEGELS[2018/03]
English:WATER DISPERSIBLE STEROL/STANOL ENRICHED POLYPHENOL RICH HERBAL TEAS IN AQUEOUS OR POWDERED FORMS TO REDUCE TOTAL AND LDL CHOLESTEROL LEVELS[2018/03]
French:TISANES RICHES EN POLYPHÉNOLS ENRICHIES EN STÉROLS/STANOLS, DISPERSIBLES DANS L'EAU, SOUS FORME AQUEUSE OU PULVÉRULENTE, SERVANT À RÉDUIRE LES NIVEAUX DE CHOLESTÉROL TOTAL ET LDL[2018/03]
Entry into regional phase21.09.2017National basic fee paid 
21.09.2017Designation fee(s) paid 
21.09.2017Examination fee paid 
Examination procedure11.01.2017Request for preliminary examination filed
International Preliminary Examining Authority: EP
07.09.2017Date on which the examining division has become responsible
21.09.2017Examination requested  [2018/03]
31.10.2018Communication of intention to grant the patent
24.12.2018Fee for grant paid
24.12.2018Fee for publishing/printing paid
28.02.2019Receipt of the translation of the claim(s)
Opposition(s)27.01.2020No opposition filed within time limit [2020/14]
Fees paidRenewal fee
21.09.2017Renewal fee patent year 03
16.07.2018Renewal fee patent year 04
13.03.2019Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.03.201804   M06   Fee paid on   16.07.2018
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.03.2015
AL24.04.2019
AT24.04.2019
CY24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
MK24.04.2019
MT24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
[2022/32]
Former [2022/28]HU11.03.2015
AL24.04.2019
AT24.04.2019
CY24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
MT24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/50]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
MC24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/26]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SI24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/17]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
SM24.04.2019
TR24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/14]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
SM24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/12]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
IT24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/11]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
EE24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
SK24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/10]AL24.04.2019
AT24.04.2019
CZ24.04.2019
DK24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RO24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/09]AL24.04.2019
CZ24.04.2019
DK24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2020/04]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
IS24.08.2019
PT24.08.2019
Former [2019/52]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
PL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/51]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
RS24.04.2019
SE24.04.2019
BG24.07.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/50]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
LV24.04.2019
NL24.04.2019
RS24.04.2019
SE24.04.2019
NO24.07.2019
GR25.07.2019
PT24.08.2019
Former [2019/49]AL24.04.2019
ES24.04.2019
FI24.04.2019
HR24.04.2019
LT24.04.2019
NL24.04.2019
SE24.04.2019
NO24.07.2019
PT24.08.2019
Former [2019/48]ES24.04.2019
FI24.04.2019
LT24.04.2019
NL24.04.2019
SE24.04.2019
NO24.07.2019
PT24.08.2019
Former [2019/47]ES24.04.2019
FI24.04.2019
LT24.04.2019
NL24.04.2019
NO24.07.2019
Former [2019/44]NL24.04.2019
Cited inInternational search[X]WO2006020131  (WINDOW ROCK ENTPR INC [US], et al) [X] 1,2* claims 2-4 *;
 [XD]WO2006074752  (UNILEVER NV [NL], et al) [XD] 1,2,4 * page 4, line 30 - page 7, line 23; example - *;
 [XI]EP2070429  (COGNIS IP MAN GMBH [DE]) [X] 1,2,4 * paragraphs [0009] - [0018] - [0021]; examples 1-3; claim - * [I] 1-25;
 [X]WO2009076742  (MULTI FORMULATIONS LTD [CA], et al) [X] 1,2,4 * examples 1-4 *
by applicantUS3163539
 US3751569
 US3881005
 US4195084
 US4639375
 US5578334
 EP0897671
 WO0061694
 WO03105611
 WO2006074752
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.